Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2009-09-30
2011-12-27
Bunner, Bridget E (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S471000, C435S325000, C536S023500, C530S351000
Reexamination Certificate
active
08084232
ABSTRACT:
Isolated polynucleotides encodingPapio cynocephalusToll-Like Receptor 3 (Baboon TLR3), polypeptides obtainable from expression of these polynucleotides, recombinant cells, and methods of use are disclosed.
REFERENCES:
patent: 5543131 (1996-08-01), Levy
patent: 2007/0072202 (2007-03-01), Bates et al.
patent: 2007/0098716 (2007-05-01), Duffy et al.
patent: 2007/0253982 (2007-11-01), Song et al.
Alexopoulou et al, Nature, 2001, vol. 413, pp. 732-738.
Bell et al, PNAS, 2005, vol. 102, No. 31, pp. 10976-10980.
Cho et al, Science, 2005, vol. 309, pp. 581-585.
PCT International Search Report dated Mar. 16, 2010.
Dogusan, et al., “Double-Stranded RNA Induces Pancreatic β-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways,” Diabetes, 57: 1236-1245 (2008).
Anthony Gaspari, “Innate and adaptive immunity and the pathophysiology of psoriasis,” Journal of the American Academy of Dermatology, 54: S67-S80 (2006).
Hoffman, et al., “TLR-targeted therapeutics,” Nature Review Drug Discovery, 4: 879-880 (2005).
Kanzler, et al., “Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists,” Nature Medicine, 13: 552-559 (2007).
Lancaster, et al., “The physiological regulation of toll-like receptor expression and function in humans,” Journal of Physiology, 563: 945-955 (2005).
Loisel, et al., “Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment,” Critical Reviews in Oncology/Hematology, 62: 34-42 (2007).
Le Goffic, et al., “Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus-Induced Acute Pneumonia,” PloS Pathogens, 2: E53 (2006).
Pierre Miossec, “An update on the cytokine network in rheumatoid arthritis,” Current Opinion in Rheumatology, 16: 218-222 (2004).
Ogata, et al., “Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease,” Current Pharmaceutical Design, 9: 1107-1113 (2003).
Picha, et al., “Protein Engineering Strategies for Sustained Glucagon-Like peptide-1 Receptor-Dependent Control of Glucose Homeostasis,” Diabetes, 57: 1926-1934 (2008).
Nina Rezaei, “Therapeutic targeting of pattern-recognition receptors,” International Immunopharmacology, 6: 863-869 (2006).
Francois Romagne, “Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors,” Drug Discovery Today, 12(1/2): 80-87 (2007).
Stumpp, et al., “DARPins: A true alternative to antibodies,” Current Opinion in Drug Discovery & Development, 10(2): 153-159 (2007).
Tabeta, et al., “Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection,” Proceedings of the National Academy of Science USA, 101: 3516-3521 (2004).
Takeda, et al., “Microbial recognition by Toll-like receptors,” Journal of Dermatological Science, 34: 73-82 (2004).
Takii, et al., “Enhanced expression of type 1 interferon and toll-like receptor-3 in primary biliary cirrhosis,” Laboratory Investigations, 85: 908-920 (2005).
David M. Underhill, “Toll-like receptors and microbes take aim at each other,” Current Opinion in Immunology, 16: 483-487 (2004).
Van Amersfoort, et al., “Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock,” Clinical Microbiology Reviews, 16(3): 379-414 (2003).
Ingrid Wickelgren, “Targeting the Tolls,” Science, 312: 184-187 (2006).
Zhou, et al., “Recognition of Double-Stranded RNA by TLR3 Induces Severe Small Intestinal Injury in Mice,” Journal of Immunology, 178: 4548-4556 (2007).
Jordan Jarrat
Schreiter Jessica
Swencki-Underwood Bethany
Baumeister Kirk
Bunner Bridget E
Centocor Ortho Biotech Inc.
Hamud Fozia
LandOfFree
Polynucleotides encoding Papio cynocephalus toll-like... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides encoding Papio cynocephalus toll-like..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding Papio cynocephalus toll-like... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4316033